Neurosciences · 2019 · 10 citations · 7 references
MedicineNeurologyPhysiologyExercise PhysiologyNeuromuscular DisordersNeuropathologyElectrolyte DisordersIon Channel DisordersMuscle DisordersPotassium HomeostasisClinical Laboratory EvaluationDisorderHypokalemia TreatmentLaboratory Test EvaluationPotassium Channel Gene DisordersPotassium ChannelopathiesPotassium Homeostasis AbnormalitiesRespiratory Muscles
Hypokalemic periodic paralysis (HypoPP) is a relatively rare but treatable disorder caused by mutations in the CACNA1S gene. HypoPP patients may experience paralytic episodes associated with hypokalemia and, infrequently, may develop late-onset proximal myopathy. The paralytic attacks are characterized by reversible flaccid paralysis and, in most cases, spare the respiratory muscles and heart. We report a case of CACNA1S periodic paralysis precipitated by vigorous exercise in a 14-year-old boy who presented with sudden-onset paralysis of both his upper and lower extremities. Laboratory evaluation revealed a markedly low serum potassium level. The patients symptoms resolved after correction of the potassium abnormality, and he was discharged with no neurological deficits. Although rare, HypoPP must be differentiated from other causes of weakness and paralysis so that proper treatment can be promptly initiated to ensure good outcomes.
7
Voltage sensor charge loss accounts for most cases of hypokalemic periodic paralysis
Emma Matthews, Robyn Labrum, Mary G. Sweeney et al. · Neurology · 2008 · 202 citations · Full text
Acetazolamide efficacy in hypokalemic periodic paralysis and the predictive role of genotype
Emma Matthews, Simona Portaro, Richa Sud et al. · Neurology · 2011 · 110 citations · Full text